Hedge Fund - Two Seas Capital
Arbutus Biopharma Corp (ABUS)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $60,553,850 | 1.25% | 12,589,158 | $4.50 |
| 2 | 2025 - Q3 (2025-09-30) | $49,900,325 | 0.8% | 10,991,261 | $3.67 |
| 3 | 2025 - Q2 (2025-06-30) | $32,269,850 | 0.54% | 10,443,317 | $3.32 |
| 4 | 2025 - Q1 (2025-03-31) | $33,036,186 | 1.04% | 9,465,956 | $3.33 |
| 5 | 2024 - Q4 (2024-12-31) | $28,582,926 | 2.46% | 8,740,956 | $3.68 |
| 6 | 2024 - Q3 (2024-09-30) | $32,291,444 | 5.23% | 8,387,388 | $3.84 |
| 7 | 2024 - Q2 (2024-06-30) | $26,486,711 | 4.3% | 8,571,751 | $3.00 |
| 8 | 2024 - Q1 (2024-03-31) | $20,232,172 | 3.96% | 7,841,927 | $2.59 |
| 9 | 2023 - Q4 (2023-12-31) | $22,604,818 | 5.51% | 9,041,927 | $1.96 |
| 10 | 2023 - Q3 (2023-09-30) | $16,810,061 | 3.37% | 8,280,818 | $2.10 |
| 11 | 2023 - Q2 (2023-06-30) | $19,045,881 | 4.16% | 8,280,818 | $2.60 |
| 12 | 2023 - Q1 (2023-03-31) | $22,618,114 | 20.75% | 7,464,724 | $2.82 |
| 13 | 2022 - Q4 (2022-12-31) | $17,484,770 | 16.6% | 7,504,193 | $2.39 |
| 14 | 2022 - Q3 (2022-09-30) | $10,799,000 | 9.86% | 5,653,917 | $2.35 |
| 15 | 2022 - Q2 (2022-06-30) | $9,490,000 | 12.35% | 3,501,876 | $2.56 |
| 16 | 2022 - Q1 (2022-03-31) | $6,553,000 | 5.49% | 2,199,069 | $3.06 |
| 17 | 2021 - Q4 (2021-12-31) | $3,211,000 | 2.46% | 825,569 | $3.88 |
The displayed share prices are average quarterly stock market prices.
The share numbers are adjusted according to following stock splits:
-
1.0000:5.0000 on 2010-11-04
Hedge Fund Resource Center